Measurement of neutralising antibodies to type I interferons by gene expression assays specific for type 1 interferon-inducible 6-16 mRNA

This publication has 16 references indexed in Scilit:

• Development of a bioassay for quantification of neutralising antibodies against human interferon-beta in mouse sera
  Journal of Immunological Methods, 2008
• Quantification of Neutralizing Antibodies to Human Type I Interferons Using Division-Arrested Frozen Cells Carrying an Interferon-Regulated Reporter-Gene
  Journal of Interferon & Cytokine Research, 2008
• Measured Neutralizing Titers of IFN-β Neutralizing Antibodies (NAbs) Can Depend on the Preparations of IFN-β Used in the Assay
  Journal of Interferon & Cytokine Research, 2007
• Development and validation of a real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta
  Journal of Immunological Methods, 2007
• Interferon beta preparations for the treatment of multiple sclerosis patients differ in neutralizing antibody seroprevalence and immunogenicity
  Multiple Sclerosis Journal, 2007
• Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: A comparison of three methods in a large Australasian cohort
  Journal of Immunological Methods, 2006
• Biological activity of interleukins-28 and -29: Comparison with type I interferons
  Cytokine, 2005
• G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell
  Cancer Immunology, Immunotherapy, 2005
• Identification of a novel gene family that includes the interferon-inducible human genes 6–16 and ISG12
  BMC Genomics, 2004
• A Novel Bioassay for the Determination of Neutralizing Antibodies to IFNβ1b
  Journal of Interferon & Cytokine Research, 1998